EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

GlaxoSmithKline vet departs for Vifor, the rumored target of a $7.1B CSL buyout

With a recent pruritus approval in the books and several more potential launches coming in the next year and a half, Switzerland’s Vifor Pharma is tapping longtime Gl...
Continue Reading →
Catalyst: 12th January 2026
Quotient